Chronic Strongyloides stercoralis infection in Fijian migrants to the UK

, the human threadworm, is a parasitic nematode with global distribution, estimated to infect over 600 million people. Chronic infection is often asymptomatic, but hyperinfection and dissemination syndromes can occur in the immunosuppressed with high case fatality rates. Whilst strongyloidiasis is endemic in Fiji, its prevalence in Fijian migrant groups in the UK is unknown. No previous studies have been conducted on the prevalence of and other gastrointestinal parasites (GIPs) in Fijian migrants to the UK. We conducted a cross-sectional study of the prevalence of GIPs in a Fijian migrant population. Participants completed a questionnaire on residence, travel and clinical symptoms and were asked to provide a serum sample for IgG ELISA, venous blood samples for eosinophil count and a faecal sample for charcoal culture, multiplex real-time PCR (rtPCR) and microscopy after formalin-ethyl acetate concentration. Sequencing was performed on pooled larvae for nuclear 18S rRNA hyper-variable regions (HVRs) I and IV. A total of 250 participants (94% male) with median (range) age 37 (20-51) years entered the study, 15 (1-24) years since leaving Fiji. IgG ELISA was positive in 87/248 (35.1 %) and 14/74 (18.9 %) had a GIP detected in faeces. This included 7/74 (9.5 %) with and 5/74 (6.8 %) with hookworms. Dermatological symptoms were more common in those with and eosinophilia (>0.5×10 cells per litre) was present in 55.6% of those with positive IgG. rtPCR was the most sensitive faecal diagnostic test for and hookworms in faeces. Sequences of nuclear 18S rRNA for HVRs I and IV confirmed the presence of . This first cross-sectional study in Fijian migrants found a high rate of chronic infection with GIPs, particularly . Faecal microscopy was insensitive compared to charcoal culture, rtPCR or serology, demonstrating the importance of specialist parasitological tests when investigating people with a suspected chronic infection. Our study highlights an overlooked burden of strongyloidiasis in the UK and has implications for screening and treatment programmes in Fiji and for migrants from Fiji.